Features of biliary tract diseases in ketamine abusers: a systematic review of case reports.
Alireza Teymouri, Hadis Nasoori, Maryamsadat Fakheri, Aref Nasiri
Journal of medical case reports March 3, 2024 DOI: 10.1186/s13256-024-04421-6 via PubMed
Summary
AI-generated from the abstractKetamine abuse can cause damage to the bile ducts and liver, a condition known as cholangiopathy. A systematic review of case reports found that affected patients are typically young men around 26 years old, presenting with abdominal pain, nausea, and vomiting. Imaging often shows dilation of the common bile duct. Most patients improve with supportive care, but the condition requires a multidisciplinary management approach. The review highlights the need to consider ketamine abuse in young patients with unexplained biliary symptoms and abnormal liver function.
Study at a glance
| Characteristics | Systematic review Case report Peer reviewed |
|---|---|
| Sample size | 17 |
| Population | Adult patients with documented ketamine abuse and cholangiopathy or biliary tract disease |
| Topics | Addiction Ketamine |
| Keywords | Biliary tract disease Substance abuse Ketamine abuse Biliary disease Drug-induced cholangiopathy |
| Citations | 20 |
| Key finding | Ketamine-induced cholangiopathy typically presents in young men with abdominal pain, abnormal liver function, and bile duct dilation, and most patients improve with supportive care. |
Abstract
Anesthesiologists prefer ketamine for certain surgeries due to its effectiveness as a non-competitive inhibitor of the N-methyl-D-aspartate receptor in the brain. Recently, this agent has also shown promise as an antidepressant. However, ketamine can cause hallucinogenic effects and is sometimes abused as an illicit drug. Ketamine abuse has been associated with liver and bile duct complications. This systematic study aims to better understand cholangiopathy in ketamine abusers by reviewing case reports. In this systematic review, a comprehensive literature search was conducted with the terms "biliary tract diseases" and "ketamine". Case reports and case series of adult patients with documented ketamine abuse and reported cholangiopathy or biliary tract disease were included. We extracted the data of relevant information and the results were reported through narrative synthesis and descriptive statistics. A total of 48 studies were initially identified, and 11 studies were finally included in the review. The mean age of the patients was 25.88 years. Of the 17 patients, 64.7% were men. Symptoms often included abdominal pain, nausea, and vomiting. Most patients were discharged with improved symptoms and liver function. Common bile duct dilation and other findings were observed in imaging results and other diagnostic studies. This review highlights the diverse presentations and diagnostic modalities used in ketamine-induced cholangiography. These patients tend to be young men with deranged liver function tests and abdominal pain, which should be taken into consideration. These patients often require a multidisciplinary approach in their management.